top of page

Dr. Cindy Bednasz
Assistant Director of Clinical Pharmacology and Quality Manager, is primarily responsible for project support, documentation development, and scientific writing at ePD. Cindy received a Pharm.D. degree from SUNY at Buffalo in 2006, completed a PGY-1 general practice residency at Strong Memorial Hospital in 2007, received an M.S. degree in Pharmaceutical Sciences from SUNY at Buffalo in 2018, and completed a 2-year fellowship in clinical pharmacology the same year. Cindy has worked in multiple healthcare and clinical research settings throughout her career. She is the author or co-author of 6 peer-reviewed scientific publications, primarily involving HIV and antiretroviral therapy. Cindy is also an Adjunct Assistant Professor in the School of Pharmacy Practice at SUNY-Buffalo.

Mr. Eric Santulli
Scientist, AI/ML / Software Developer. Eric obtained his BS degree in Computer Science from the University at Buffalo, SUNY with a concentration in artificial intelligence and machine learning, and prior to joining ePD, served as a Full Stack Developer in the data sciences field. Eric brings with him vast knowledge and experience in applying AI methods to complex datasets, and at ePD, he is focused on applying these methods in the drug development space, as well as contributing to our flagship software, Finch Studio.

Mrs. Carla Scaglione
​
Office Manager, coordinates accounting, payroll and bookkeeping activities as well as assisting with facility management. Carla previously received a Masters degree in Occupational Therapy from D'Youville College.

Dr. Sarah F. Cook
Associate Director of Pharmacometrics, primarily acts as a project leader on pre-clinical and clinical modeling projects at ePD. Sarah received a Ph.D. degree in Pharmacology and Toxicology and M.S. degree in Clinical Investigation from the University of Utah. Prior to joining ePD, Sarah worked first as a Postdoctoral Associate and later as a Research Assistant Professor in the Department of Pharmaceutical Sciences at the University at Buffalo, SUNY with research focused on modeling and simulation in oncology via collaboration with Roswell Park Cancer Institute. Sarah has over 15 yr experience working in clinical pharmacology, and her pharmacometric expertise includes statistical analysis, population PK–PD analysis, and mechanism-based modeling. She has taught population PK–PD analysis in numerous workshops and courses and is an Adjunct Assistant Professor of Pharmaceutical Sciences at the University at Buffalo, SUNY.

Dr. Mohamed Ismail
Director, Quantitative Pharmacology. Mohamed received his Pharm,D. and MS degree in Pharmaceutical Sciences from University at Buffalo, SUNY working with Dr. Robert Bies. Prior to coming to ePD, Mohamed spent three years in the Clinical Pharmacology group at AbbVie Pharmaceutics. Mohamed supervises the pharmacometrics group at ePD, and leads our software development and analytical tool platforms.

Ms. Calista Van Wart
Data Scientist. Calista Received a BSPH in public health and epidemiology from Virginia Tech and a MPH degree from University at Buffalo, SUNY. Calista provides data management support, coordinates literature data extraction, and provides statistical support at ePD.

Mr. Andrew Santulli
Associate Director, Quantitative Sciences and AI/ML, is involved with a variety of pharmacokinetic and pharmacokinetic-pharmacodynamic modeling projects, QSP projects, AI/ML applications, clinical trial simulations, and R Shiny application development, at ePD. Andrew graduated summa cum laude with a BSE degree in biomedical engineering from Case Western Reserve University in 2019 and obtained a MS in Pharmaceutical Sciences at University at Buffalo, SUNY under the guidance of Dr. Robert Bies.

Dr. Krutika Patidar
Scientist, Quantitative Sciences and Systems Pharmacology. Krutika obtained her PhD from the University at Buffalo’s Department of Chemical and Biological Engineering under the direction of Dr. Ashlee Ford Versypt. Krutika also recently completed an internship at Sanofi DMPK, where she designed and applied creative AI/ML solutions to predict rule-based criteria for biologics-targets and developed a mechanistic PBPK model to relate antibody properties to their ADME, PK, TMDD, and PD through receptor engagement.

Dr. Nhan Nguyen
Scientist, Pharmacometrics and Translational PK-PD. Nhan received her PhD degree in Pharmaceutical Sciences from the University at Buffalo, SUNY under the guidance of Dr. Balu Sathy-Iyer. Nhan is a recognized expert in immunology and provides project management, population PK and PK-PD support on a variety of therapeutica areas at ePD.
bottom of page



